紧跟技术创新:介入肺脏病学中实用性临床试验的道德必要性
过去十年微创肺癌诊断技术的进步改变了患者护理,但也引发了对监管审批流程和证据生成方式的担忧。机器人支气管镜等颠覆性技术在缺乏改善患者结局的稳健数据下被广泛采用。本文通过两项导航支气管镜随机对照试验说明实用性临床试验的优势与局限,并指出法规清晰度、资金支持和激励对齐是主要障碍与促进因素。
要点
- 机器人支气管镜等新技术在缺乏稳健结局数据下被广泛采用,需比较效果研究。
- 实用性临床试验将试验流程整合到常规临床护理中,是生成急需数据的可行替代方案。
- 推广实用性试验需明确研究法规、充足资金及临床医生、研究者、监管者与产业界的激励对齐。
核心结论
- 实用性临床试验是生成介入肺脏病学新技术比较效果数据的道德必要途径。
研究设计与样本
- 本文为观点文章,通过两项已完成的导航支气管镜随机对照试验说明研究范式的优势与局限。
主要发现
- 机器人支气管镜等颠覆性技术在缺乏改善患者结局的稳健数据下被介入肺脏病学家广泛采用。
- 传统临床试验方法(研究团队与临床团队分离)不适合快速评估市场新技术的安全性和有效性。
临床怎么用
- 临床医生应认识到新技术采用需比较效果数据支持,实用性试验可整合到常规护理中生成证据。
局限性
- 原文未报告具体研究数据或样本量,仅以两项导航支气管镜随机对照试验为例说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The advances in minimally invasive lung cancer diagnostics of the last decade have transformed patient care but have also raised important concerns about the regulatory processes used to approve new devices and the best way to generate data to support their use. Disruptive technologies, such as robotic bronchoscopy, have been widely adopted by interventional pulmonologists in the absence of robust data demonstrating improved patient outcomes. Comparative research is needed to inform patient care, but traditional methods of conducting clinical trials in which research teams operate separately from clinical teams are ill-suited to testing the safety and effectiveness of technologies being introduced on the market at unprecedented speed. Pragmatic clinical trials, which integrate trial procedures into routine clinical care, represent an appealing alternative approach for generating much-needed data to inform clinical care. In this article we illustrate the advantages and disadvantages of these research paradigms, using two recently completed randomized controlled trials in navigational bronchoscopy, and highlight the barriers and facilitators to using pragmatic trials to address the gap in comparative effectiveness research: these include the need for increased clarity of research regulations for pragmatic trials, adequate federal and private funding for such research, and alignment of incentives between clinicians, researchers, regulators, and industry.
引用
- Maldonado F, Paez R, Lentz RJ, et al. Keeping Up With Technological Innovation: The Moral Imperative for Pragmatic Clinical Trials in Interventional Pulmonology. Chest. 2024. PMID: 39577764. doi:10.1016/j.chest.2024.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。